Appointment of Mr. Ravi Prakash Bhagavathula as an Executive Director
Stock Exchange Intimation – Analyst Call – Financial Results for the quarter ended December 31, 2016
Notice of Board Meeting – January 30, 2017
Granting of authority to the Company by AstraZeneca Pharma India Limited for certain rights in relation to identified injectable antibiotic products through a Delegation of Authority.
Stock Exchanges Intimation – Meeting with Analyst / Institutional Investor – January 12, 2017